EUVIMED · CrossrefJournal
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
ISSN 1872-2148 · Bentham Science Publishers Ltd.
Latest articles
Biological Activities of Red Propolis: A Review
Alterations in Glucose Metabolism in Alzheimer's Disease
Innovative Models for the Empowerment of Patients with Type 2 Diabetes: The CAIPaDi Program
Current Research on How Infertility Affects the Sexuality of Men and Women
Role of Mitochondria on Muscle Cell Death and Meat Tenderization
HMGB-1 as a Target for Inflammation Controlling
Anti Diabetic Effect of Cherries in Alloxan Induced Diabetic Rats
Fetuin-A: A Multifunctional Protein
Pharmacoperones: A New Therapeutic Approach for Diseases Caused By Misfolded G Protein-Coupled Receptors
Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy
Effect of Fasting Ramadan in Diabetes Control Status - Application of Extensive Diabetes Education, Serum Creatinine with HbA1c Statistical ANOVA and Regression Models to Prevent Hypoglycemia
Associations between Periodontitis and Systemic Inflammatory Diseases: Response to Treatment
The Dual Role of Free Fatty Acid Signaling in Inflammation and Therapeutics
Patent Selections
Development of Prolactin Receptor Antagonists: Same Goal, Different Ways
Melatonin as Antioxidant Under Pathological Processes
Dipeptidyl Peptidase-IV Inhibitors: An Evolving Treatment for Type 2 Diabetes from the Incretin Concept
Molecular Targets for Promoting Wound Healing in Diabetes
Stimuli-induced Pulsatile or Triggered Release Delivery Systems for Bioactive Compounds
Patent Annotations
C75, a Fatty Acid Synthase (FAS) Inhibitor
Insulin Delivery Systems for Controlling Diabetes
Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
Neural Pathways and Neuropeptides Mediate the Therapeutic Actions of DPP IV Inhibitors in Type-2 Diabetes
Cardiac Fat as New Diagnostic Tool and Potential Therapeutic Target for Obesity Management and Treatment
Melatonin and Melatoninergic Drugs as Therapeutic Agents: Ramelteon and Agomelatine, the Two Most Promising Melatonin Receptor Agonists
Patent Selections
Hepatic Nuclear Factor-4, a Key Transcription Factor at the Crossroads Between Architecture and Function of Epithelia
The Pineal Gland and Beneficial Effects of Melatonin
EUVIMED